Chemicals and Drugs

Ustekinumab

A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.

National Library of MedicineMedical Subject Headings2026

Structured Summary

Abstract

A humanized monoclonal antibody that binds to IL-12 and IL-23 and is used as a DERMATOLOGIC AGENT in the treatment of patients with plaque PSORIASIS who have not responded to other therapies.

MeSH Record

Classification

Broader headings

Related Concepts

Knowledge Graph

Loading graph…

Drag nodes to rearrange; hover to trace links; click a node to open its page.

Drug Class

Pharmacological Action

MeSH Record

See Also

MeSH Record

Synonyms

3 entry terms
  • CNTO 1275
  • CNTO-1275
  • Stelara

MeSH Record

Aspects Covered

24 allowable subheadings

Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.

MeSH Record

History Note

2016 (2005)

MeSH Hierarchy

Tree Numbers

  1. D12.776w.124w.486.485.114w.224w.060w.937w
  2. D12.776w.124w.790.651.114w.224w.060w.937w
  3. D12.776w.377w.715.548.114w.224w.200w.937w

AMA Style

References

  1. National Library of Medicine. Ustekinumab. Medical Subject Headings (MeSH). 2026. Unique ID D000069549. http://id.nlm.nih.gov/mesh/2026/D000069549
  2. Ustekinumab. In: Wikipedia. https://en.wikipedia.org/wiki/Ustekinumab
  3. Ustekinumab. In: Wikidata. https://www.wikidata.org/wiki/Q420305